AtriClip® LAA Exclusion System PRO240Recalls & reported problems
Atricure, Inc. · AtriClip® PRO2 Gillinov-Cosgrove LAA Exclusion System 40 · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10840143900181), received between May 13, 2022 and Sep 14, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Use of Device Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Use of Device Problem1
Patient problems
- Cardiac Perforation1
- Thrombosis/Thrombus1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjurySep 14, 2023Use of Device Problem; Use of Device Problem
ON (B)(6) 2023 A 73-YEAR-OLD MALE PATIENT UNDERWENT A HYBRID (CONVERGENT APPROACH) ABLATION PROCEDURE WITH CONCOMITANT LEFT ATRIAL APPENDAGE EXCLUSION. THE ABLATION PROCEDURE WAS COMPLETED SUCCESSFULLY. WHILE MANIPULATING THE LEFT ATRIAL APPENDAGE WITH AN ENDOSCOPIC KITTNER AND POSITIONING THE PRO240 ATRICLIP DEVICE, BLEEDING WAS OBSERVED. THE PROCEDURE WAS CONVERTED TO MEDIAN STERNOTOMY APPROACH AND THE INJURY, LOCATED AT THE BASE OF THE PULMONARY ARTERY AND RIGHT VENTRICULAR OUTFLOW TRACT, WAS REPAIRED SUCCESSFULLY. POST-OPERATIVELY, THE PATIENT DEVELOPED SEPSIS AND EXPIRED. IT IS UNKNOWN IF AN AUTOPSY WILL BE CONDUCTED TO DETERMINE CAUSE OF DEATH. THERE WAS NO REPORTED DEVICE MALFUNCTION, AND THE ADVERSE EVENT WAS THE RESULT OF A PROCEDURAL COMPLICATION.
Patient problems: Cardiac Perforation
MAUDE report 17749825 ↗InjuryMay 13, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2022 A PATIENT UNDERWENT A ROBOTIC CRYO MAZE WITH CONCOMITANT LEFT ATRIAL APPENDAGE MANAGEMENT. PRIOR TO CLIP PLACEMENT, THE PHYSICIAN NOTICED A THROMBUS IN THE LAA, BUT PROCEEDED WITH THE PROCEDURE. THE CLIP WAS DEPLOYED AND DURING DEPLOYMENT THE THROMBUS MIGRATED INTO THE LEFT ATRIUM AND THEN OUT OF THE ATRIUM INTO THE BODY. POST-PROCEDURE, THE CLOT EMBOLIZED TO LEFT KIDNEY AND WAS REMOVED IN A FOLLOW-UP PROCEDURE. THE PATIENT IS DOING WELL AND THERE WERE NO LONG-TERM COMPLICATIONS. THIS WAS A PROCEDURAL COMPLICATION WITH NO REPORTED DEVICE MALFUNCTION.
Patient problems: Thrombosis/Thrombus
MAUDE report 14394557 ↗
Other Clip, Implantable devices
- LIGAMAX EL5MLEthicon Endo-Surgery, LLC · CLIP, IMPLANTABLE3 deaths3,808 reports
- Endo Clip III 176630Covidien LP · CLIP, IMPLANTABLE1 death1,959 reports
- Epix® Universal Clip Applier CA500Applied Medical Resources Corporation · Clip, Implantable1 recall1 death1,183 reports
- Endo Clip II 176657Covidien LP · CLIP, IMPLANTABLE1,183 reports
- LIGACLIP ER320Ethicon Endo-Surgery, LLC · CLIP, IMPLANTABLE1,115 reports
- Direct Drive® Clip Applier CA090Applied Medical Resources Corporation · Clip, Implantable1 death806 reports
- LAPRA-TY XC200Ethicon Inc. · CLIP, IMPLANTABLE791 reports
- Endo Clip 176625Covidien LP · CLIP, IMPLANTABLE1 death768 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page